Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kerra Thai traditional herbal medicine for early-stage COVID-19 symptoms
TCTR20230706003Phase 2Completed
- Sponsor
- Eastern Herb Company
- Start
- Sep 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Kerra in coronavirus disease 2019 (COVID-19), sponsored by Eastern Herb Company. Started Sep 2022; status: completed.
02
Drugs
Kerra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20230706003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230706003.